INDIA –Tata 1mg, India’s largest digital health platform, announced today the opening of its first Reference Lab in Delhi, which was inaugurated by Dr. Indu Bhushan, former CEO of Ayushman Bharat.
The cutting-edge reference diagnostics laboratory can process up to 4000 tests per hour and joins Tata 1mg’s already extensive nationwide network of 8 diagnostic labs that serve over a million customers each year across 30 cities.
Tata 1mg has established itself as one of India’s leading diagnostics players since its foray into e-diagnostics in 2016, earning consumer trust and loyalty by consistently delivering a superior experience.
Tata 1mg AS one of the early movers in online diagnostics, is slowly building its presence in the space after rival PharmEasy acquired national diagnostics chain Thyrocare last year.
Tata 1mg, previously 1mg, which started its diagnostics services in 2016, now draws 15 per cent of its revenues from this vertical.
Because of industry-leading on-time collection rates, quick report delivery, clinically robust processes, and a highly professional and trained team, the brand has one of the highest customer satisfaction scores in the healthcare industry.
The new Reference Lab in Delhi is spread across 24000 sq. feet area and is equipped to process more than 4000 tests per hour across pathology and microbiology specializations.
Tata 1mg’s network of labs works with best in class quality assurance and provides a comprehensive range of routine, specialized and esoteric tests covering the whole spectrum of clinical diagnostics.
Technology-enabled and fully automated systems track end to end sample movement from collection to reporting, thus eliminating pre-analytical errors.
The labs are led by a strong and highly experienced team of pathologists, microbiologists, biochemists and molecular scientists who are further supported by the brand’s existing network of 1000+ phlebotomists for home sample collection.
Gaurav Agarwal, Co-Founder, Tata 1mg said, “Opening of a reference lab is an important milestone in Tata 1mg’s journey towards becoming India’s most trusted diagnostics brand.
“Our new lab provides us with an ability to expand our range of services while staying synonymous with reliability, trustworthiness and convenience.
“We are humbled by the trust millions of customers have shown in our existing healthcare services and we will continue to further strengthen our offerings and grow our network and expertise, to become the first choice of healthcare brand for consumers, doctors and caregivers across the country.”
Liked this article? Sign up to receive our regular email newsletters, focused on Africa and World’s healthcare industry, directly into your inbox. SUBSCRIBE HERE